Thought Leadership
Gillson Sciences’ thought leadership explores the science, regulatory expectations, and operational realities behind pharmaceutical and cleanroom testing. Through expert articles, whitepapers, and technical insights, we share practical guidance to help quality and manufacturing leaders strengthen contamination control, improve compliance, and protect product integrity.
Recent Thoughts
AI in Visual Inspection Is Not a Technology Decision. It’s a Quality System Decision.
Every visual inspection vendor is selling AI right now. The pitches are familiar: better detection sensitivity, lower false reject rates, faster line speeds, more consistent classification. Some of these claims are true. Some are partially true. All of them are beside the point if the buyer’s quality system is not ready to qualify, validate, and maintain an AI model under cGMP.
Read More
Your Single-Use System Is Shedding Particles. Here’s How to Decide Which Ones Actually Matter.
Read More
Stop Treating Subvisible Particles as a Release Test. Start Using Them as an Early Warning System.
By the time a visible particle appears in a vial, the upstream event that created it happened days or weeks earlier. SVP trends, monitored deliberately, move long before that visible defect shows up. The question is whether your program is set up to listen to these early warnings.
Read More
Clean Steam in Pharmaceutical Manufacturing: What Quality Leaders Need to Know to Avoid Costly Mistakes
Clean steam is the quiet workhorse of sterile manufacturing. It sterilizes equipment, supports SIP/CIP cycles, protects product-contact surfaces, and underpins the integrity of aseptic operations.
Get in Touch
We're here to answer your questions, discuss your project needs, or provide a custom quote. Fill out the form below and our team will respond promptly.